21 july 2020 -With the trials of Covid-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, Adar Poonawalla of the Serum Institute of India (SII) has said at least 300 million doses of the potential vaccine will be ready by December.
SII Chief Executive Officer Adar Poonawalla said 300-400 million doses of the potential vaccine ‘Covishield’ will be ready by December.
“Covishield is going to be the first Covid-19 vaccine we hope to launch if trials are successful in the UK and India,” SII CEO Adar Poonawalla told India Today. Adar Poonawalla added that they expect the vaccine to reach the people of India in large numbers by the first quarter of 2021.
Adar Poonawalla of the Serum Institute added that the vaccine will cost around Rs 1,000 in India.